Scancell Holdings PLC (SCLP)

Back to homepage

Company Description

Scancell Holdings PLC was incorporated on April 14, 2008. The Company is a biopharmaceutical company. The Company is engaged in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer. The Company develops medications to cure cancer by spurring the body's immune system. The Company's ImmunoBody vaccines generate potent killer T-cells that target and eliminate tumors. The Company's product SCIB2 ImmunoBody vaccine targets tumours expressing the NY-ESO-1 antigen. Moditope stimulates the production of killer CD4 T-cells with powerful anti-tumour activity without toxicity...